3Martel-Pellefier J. Pathophysiology of osteoarthritis[J]. Osteoa Cartil, 2004,12 (Suppl A) : 31-33.
4Migliore A,Granata M, Tormenta S, et al. Hip viscosup- plementation under ultra-sound guidance riduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry[J]. Eur Rev Med Pharmacol Sci, 2011,15 ( 1 ) : 25-34.
5Jorgensen A, Stengaard-Pedersen K, Simonsen O, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis., a multicentre, randomized, placebo- controlled, double-bl ind study of 337 patients followed for 1 year[J]. Ann Rheum Dis,2010,69(6):1097-1102.
6Conrozier T, Jerosch J, Beks P, et al. Prospective, multi- centre,randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F20 in patients with symptomatic tibio-femoral osteoar- thritis., a pilot study[J]. Arch Orthop Trauma Surg, 2009, 129(3) :417-423.
7Hlavacek M. The role of synovial fl uid filtration bycarti- lage in lubration of synovial joints[J]. J Biomech, 1993,26(10):1151-1160.
8Huang MH, Yang RC, Lee CL, et al. Preliminary results of integrated therapy for patients with knee osteoarthritis [J]. Arthritis Rheum,2005,53(6) :812-820.
9Moreland LW. Intra-articular hyaluronan(hyaluronic acid)and hylans for the treatment of osteoarthritis:mechanisms of action[J]. Arthritis Res Ther, 2003,5 (2) : 54-67.
10Lequesne M, Maheu E, Cadet C, et al. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip [J]. Arthritis Rheum, 2002, 47 (1) : 50-58.
